DE3850019D1 - Rekombinantes Avipoxvirus. - Google Patents

Rekombinantes Avipoxvirus.

Info

Publication number
DE3850019D1
DE3850019D1 DE3850019T DE3850019T DE3850019D1 DE 3850019 D1 DE3850019 D1 DE 3850019D1 DE 3850019 T DE3850019 T DE 3850019T DE 3850019 T DE3850019 T DE 3850019T DE 3850019 D1 DE3850019 D1 DE 3850019D1
Authority
DE
Germany
Prior art keywords
avipox virus
recombinant avipox
recombinant
virus
avipox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3850019T
Other languages
English (en)
Other versions
DE3850019T2 (de
Inventor
Noboru Yanagida
Sakiko Saeki
Ryohei Ogawa
Kouichi Kamogawa
Yoshiyuki Hayashi
Kazunari Sawaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Shionogi and Co Ltd
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd, Nippon Zeon Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE3850019D1 publication Critical patent/DE3850019D1/de
Publication of DE3850019T2 publication Critical patent/DE3850019T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3850019T 1987-09-16 1988-09-15 Rekombinantes Avipoxvirus. Expired - Lifetime DE3850019T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23165387 1987-09-16

Publications (2)

Publication Number Publication Date
DE3850019D1 true DE3850019D1 (de) 1994-07-14
DE3850019T2 DE3850019T2 (de) 1994-12-01

Family

ID=16926866

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850019T Expired - Lifetime DE3850019T2 (de) 1987-09-16 1988-09-15 Rekombinantes Avipoxvirus.

Country Status (5)

Country Link
EP (1) EP0308220B1 (de)
KR (1) KR970000530B1 (de)
AU (1) AU611711B2 (de)
CA (1) CA1340203C (de)
DE (1) DE3850019T2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68919846T2 (de) * 1988-02-12 1995-07-06 Commw Scient Ind Res Org Poxvirus-vektoren.
DE3813093A1 (de) * 1988-04-19 1989-11-09 Immuno Ag Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung
US5631154A (en) * 1988-06-10 1997-05-20 Therion Biologics, Incorporated Self assembled, defective, non-self-propagating lentivirus particles
ES2061996T3 (es) * 1988-06-24 1994-12-16 British Tech Group Regiones no esenciales de avipoxvirus.
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
AU623476B2 (en) * 1988-12-29 1992-05-14 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
JP2781605B2 (ja) * 1989-06-22 1998-07-30 日本ゼオン株式会社 組み換えアビポックスウイルス
KR930701588A (ko) * 1990-07-02 1993-06-12 스튜어트 알. 슈터 재조합 구두 바이러스 백신
ATE253123T1 (de) * 1991-08-26 2003-11-15 Baxter Healthcare Sa Ein intaktes fpv-tk-gen enthaltender rekombinanter virus der vogelpocken
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
WO1994023019A1 (en) * 1993-03-31 1994-10-13 Nippon Zeon Co., Ltd. Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
EP0954593A1 (de) 1996-07-25 1999-11-10 Therion Biologics Corporation Rekombinantes pockenvirus für die immunsierung gegen tumorassoziierte antigene.
GB2347932B (en) 1998-11-18 2003-05-07 Oxford Biomedica Ltd Vectors for the delivery of 5T4 antigen
CA2515890C (en) 2003-02-20 2013-09-17 Therion Biologics Corporation Novel insertion sites in pox vectors
ATE525401T1 (de) 2005-05-13 2011-10-15 Oxford Biomedica Ltd Vom tumorantigen 5t4 abgeleitete mhc-klasse-i- und ii-peptidantigene
EP2397856B1 (de) 2006-03-14 2013-11-13 Oregon Health and Science University Methoden zur Detektion einer Mycobakterium tuberculosis Infektion
EP2918598B1 (de) 2007-02-28 2019-01-30 The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Brachyurie-Polypeptide und Verwendungsverfahren
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
WO2010099472A2 (en) 2009-02-27 2010-09-02 The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services Spanx-b polypeptides and their use
CN102713629B (zh) 2009-11-20 2016-02-24 俄勒冈健康科学大学 用于检测结核分枝杆菌感染的方法
WO2012151272A2 (en) 2011-05-02 2012-11-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
EP2788021B1 (de) 2011-12-09 2017-01-18 Bavarian Nordic A/S Pockenvirus-vektor zur expression von bakteriellen antigen, welche mit tetanus toxin fragment c verbunden sind
WO2014043535A1 (en) 2012-09-14 2014-03-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions for the treatment of cancer
LT3271729T (lt) 2015-03-18 2021-02-25 Janssen Vaccines & Prevention B.V. Rekombinantinių raiškos sistemų analizės būdai
WO2023077147A2 (en) 2021-11-01 2023-05-04 Pellis Therapeutics, Inc. T-cell vaccines for patients with reduced humoral immunity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190254A4 (de) * 1984-07-05 1987-03-09 Genex Corp Kloniertes gen, verfahren zu dessen herstellung und seine verwendung.
EP0218625B1 (de) * 1985-03-29 1995-04-05 Btg International Limited Spike-protein des virus der infektiösen bronchitis
AU602875B2 (en) * 1985-12-18 1990-11-01 British Technology Group Limited Newcastle disease virus gene clones
EP0252060A1 (de) * 1986-06-30 1988-01-07 Smithkline Beckman - Animal Health Products DNA-Sequenz, rekombinante DNA-Moleküle und Verfahren zur Herstellung des von Newcastle-Krankheitsvirus-Fusionproteins oder der gleichwertigen Polypeptide, erhaltene Produkte und Präparate, die sie enthalten
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
DE3853088T2 (de) * 1987-03-27 1995-10-19 Nippon Zeon Co Rekombinantes Avipoxvirus.
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva

Also Published As

Publication number Publication date
AU2222888A (en) 1989-03-16
AU611711B2 (en) 1991-06-20
KR890005269A (ko) 1989-05-13
DE3850019T2 (de) 1994-12-01
CA1340203C (en) 1998-12-15
EP0308220A1 (de) 1989-03-22
KR970000530B1 (ko) 1997-01-13
EP0308220B1 (de) 1994-06-08

Similar Documents

Publication Publication Date Title
DE3853088D1 (de) Rekombinantes Avipoxvirus.
DE3850019D1 (de) Rekombinantes Avipoxvirus.
FR2621487B1 (fr) Virus avipox recombinant
ATE120489T1 (de) Rekombinante coccidiosis-vakzine.
DK603888D0 (da) Rekombinant virus
ATA902590A (de) Rekombinantes pockenvirus
DE4090351T1 (de) Rekombinantes Pockenvirus-Wirtsselektionssystem
DE3882144D1 (de) Gefluegelpocken-virus-promotoren.
DE3786767D1 (de) Neues polypeptid.
ATA257190A (de) Virales polypeptid
FI864016A0 (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
DE3785404D1 (de) Impfstoffe.
DE69230627D1 (de) Rekombinantes Avipoxvirus
FR2620459B1 (fr) Virus recombinant de la vaccine
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
NO881384D0 (no) Peptider.
NO885108D0 (no) Peptider.
NO873389D0 (no) Homogent rekombinant immun-interferon-fragment.
IT8821556A0 (it) Peptidi immunostimolanti.
FI895456A0 (fi) Rekombinant interleukin 2-hybridproteiner.
DE3782960D1 (de) Impfstoffe.
FI875510A (fi) Virusdoedande komposition.
EP0244427A4 (de) Rekombinantes virus.
NO872386D0 (no) Peptider.
DE3890874T1 (de) Rekombinante avipoxviren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NIPPON ZEON CO., LTD., TOKIO/TOKYO, JP